Pharmacological Treatment of Binge Eating Disorder and Frequent Comorbid Diseases.
- Published in:
- CNS Drugs, 2024, v. 38, n. 9, p. 697, doi. 10.1007/s40263-024-01111-1
- By:
- Publication type:
- Article
Works matching IS 11727047 AND DT 2024 AND VI 38 AND IP 9
Results: 6
1
2
Cenobamate as an Early Adjunctive Treatment in Drug-Resistant Focal-Onset Seizures: An Observational Cohort Study.
- Published in:
- CNS Drugs, 2024, v. 38, n. 9, p. 733, doi. 10.1007/s40263-024-01109-9
- By:
- Publication type:
- Article
3
Psychotropic Drugs Reemerging as Headache Medicines.
- Published in:
- CNS Drugs, 2024, v. 38, n. 9, p. 661, doi. 10.1007/s40263-024-01107-x
- By:
- Publication type:
- Article
4
Caregiver Perspective of Benefits and Side Effects of Anti-Seizure Medications in CDKL5 Deficiency Disorder from an International Database.
- Published in:
- CNS Drugs, 2024, v. 38, n. 9, p. 719, doi. 10.1007/s40263-024-01105-z
- By:
- Publication type:
- Article
5
When, Why and How to Re-challenge Clozapine in Schizophrenia Following Myocarditis.
- Published in:
- CNS Drugs, 2024, v. 38, n. 9, p. 671, doi. 10.1007/s40263-024-01100-4
- By:
- Publication type:
- Article
6
Patterns of Pregabalin Users from Substance Abuse Treatment Facilities: Results from the French OPPIDUM Program from 2008 to 2022.
- Published in:
- CNS Drugs, 2024, v. 38, n. 9, p. 743, doi. 10.1007/s40263-024-01095-y
- By:
- Publication type:
- Article